
Sign up to save your podcasts
Or


In which Aaron speaks with Alex Chavez, MD-PhD about antiviral drug development. They discuss chemical strategies for protease inhibitor development and the details and rationale of a novel assay that allows for early validation of candidate drugs. Additionally Alex discusses newer collaborations he is engaged in to build cellular resistance to damaging radiation.
By Columbia Sys Bio Initiative5
44 ratings
In which Aaron speaks with Alex Chavez, MD-PhD about antiviral drug development. They discuss chemical strategies for protease inhibitor development and the details and rationale of a novel assay that allows for early validation of candidate drugs. Additionally Alex discusses newer collaborations he is engaged in to build cellular resistance to damaging radiation.

43,549 Listeners

763 Listeners

12,225 Listeners

824 Listeners

87,167 Listeners

112,027 Listeners

56,481 Listeners

9,522 Listeners

5,455 Listeners

4,743 Listeners

6,551 Listeners

86 Listeners

5,506 Listeners

29,137 Listeners

15,836 Listeners